At North Point Clinical, I lead study startup and help biotechnology and pharmaceutical programs plan feasibility, vendors, risks, timelines, and regulatory strategy. I also develop project plans and study metrics, and manage inspection readiness and quality initiatives.
Previously at Emmes Biopharma, I led Phase I–III global trials across multiple regions, including a 16-country, 50-site study that achieved enrollment milestones. I managed budgets up to $15M and maintained 100% TMF inspection readiness while overseeing study delivery, vendors, and cross-functional teams.

